Musclepharm Corp Buy Hold or Sell Recommendation

MSLPDelisted Stock  USD 0  0.0002  15.38%   
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Musclepharm Corp is 'Not Rated'. Macroaxis provides Musclepharm Corp buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding MSLP positions. The advice algorithm takes into account all of Musclepharm Corp's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Musclepharm Corp's buy or sell advice are summarized below:
Real Value
0.001045
Hype Value
0.001375
Market Value
0.0011
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Musclepharm Corp given historical horizon and risk tolerance towards Musclepharm Corp. When Macroaxis issues a 'buy' or 'sell' recommendation for Musclepharm Corp, the advice is generated through an automated system that utilizes algorithms and statistical models.
  
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.
In addition, we conduct extensive research on individual companies such as Musclepharm and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Musclepharm Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.

Execute Musclepharm Corp Buy or Sell Advice

The Musclepharm recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Musclepharm Corp. Macroaxis does not own or have any residual interests in Musclepharm Corp or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Musclepharm Corp's advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Musclepharm CorpBuy Musclepharm Corp
Not Rated
For the selected time horizon Musclepharm Corp has a Risk Adjusted Performance of 0.1427, Jensen Alpha of 49.48, Total Risk Alpha of 18.31, Sortino Ratio of 0.5904 and Treynor Ratio of 2.48
We provide investment recommendation to complement the last-minute expert consensus on Musclepharm Corp. Our dynamic recommendation engine harnesses a multidimensional algorithm to analyze the entity's potential to grow using all technical and fundamental data available at the time. To make sure Musclepharm Corp is not overpriced, please verify all Musclepharm Corp fundamentals, including its cash per share and the relationship between the cash flow from operations and current asset . As Musclepharm Corp appears to be a penny stock we also strongly suggest to check its revenue numbers.

Musclepharm Corp Trading Alerts and Improvement Suggestions

Musclepharm Corp is not yet fully synchronised with the market data
Musclepharm Corp has some characteristics of a very speculative penny stock
Musclepharm Corp has a very high chance of going through financial distress in the upcoming years
The company currently holds 22.64 M in liabilities with Debt to Equity (D/E) ratio of 0.56, which is about average as compared to similar companies. Musclepharm Corp has a current ratio of 0.25, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Musclepharm Corp until it has trouble settling it off, either with new capital or with free cash flow. So, Musclepharm Corp's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Musclepharm Corp sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Musclepharm to invest in growth at high rates of return. When we think about Musclepharm Corp's use of debt, we should always consider it together with cash and equity.
The entity reported the previous year's revenue of 50.04 M. Net Loss for the year was (12.87 M) with profit before overhead, payroll, taxes, and interest of 5.37 M.
Musclepharm Corp currently holds about 534 K in cash with (8.04 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Roughly 54.0% of Musclepharm Corp outstanding shares are owned by corporate insiders

Musclepharm Corp Returns Distribution Density

The distribution of Musclepharm Corp's historical returns is an attempt to chart the uncertainty of Musclepharm Corp's future price movements. The chart of the probability distribution of Musclepharm Corp daily returns describes the distribution of returns around its average expected value. We use Musclepharm Corp price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Musclepharm Corp returns is essential to provide solid investment advice for Musclepharm Corp.
Mean Return
51.26
Value At Risk
-91.94
Potential Upside
150.00
Standard Deviation
50.06
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Musclepharm Corp historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Musclepharm Corp Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Musclepharm . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Musclepharm Corp Buy or Sell Advice

When is the right time to buy or sell Musclepharm Corp? Buying financial instruments such as Musclepharm Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Musclepharm Corp in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Medical Equipment Thematic Idea Now

Medical Equipment
Medical Equipment Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Medical Equipment theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Medical Equipment Theme or any other thematic opportunities.
View All  Next Launch
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Other Consideration for investing in Musclepharm Pink Sheet

If you are still planning to invest in Musclepharm Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Musclepharm Corp's history and understand the potential risks before investing.
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
CEOs Directory
Screen CEOs from public companies around the world
Stocks Directory
Find actively traded stocks across global markets
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities